![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1517373
¼¼°èÀÇ ÈûÁÙ µ¿Á¾ÀÌ½Ä ½ÃÀå ±Ô¸ð Á¶»ç : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)Global Tendon Allograft Market Size Study, by Product Type (Achilles Tendon, Tibialis, Patellar Tendon, Others), by End User (Hospitals, Orthopedic Clinics, Others) and Regional Forecasts 2022-2032 |
¼¼°è ÈûÁÙ µ¿Á¾ÀÌ½Ä ½ÃÀåÀº 2023³â ¾à 673¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024-2032³â ¿¹Ãø ±â°£ µ¿¾È 5.2% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àΰ£ ½Ãü¿¡¼ äÃëÇÑ ÈûÁÙ µ¿Á¾À̽ÄÀº ¼ö¼ú ½Ã°£À» ´ÜÃàÇϰí ȯÀÚÀÇ Á¶Á÷¿¡ »õ·Î¿î ¼Õ»óÀ» ÀÔÈ÷Áö ¾Ê´Â È¿À²¼ºÀ¸·Î ÀÎÇØ Âõ¾îÁö°Å³ª ¼Õ»óµÈ ÈûÁÙÀ» º¹±¸ÇÏ´Â Á¤Çü¿Ü°ú ¼ö¼ú¿¡ Á¡Á¡ ´õ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ÈûÁÙ µ¿Á¾À̽ÄÀÇ °¡°ø ¹× º¸Á¸ ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÌ½ÄÆíÀÇ º¸Á¸ ±â°£ÀÌ Å©°Ô ¿¬ÀåµÇ¾î ǰÁú ÀúÇÏ ¾øÀÌ ¼ö¼ú¿¡ »ç¿ëÇÒ ¼ö ÀÖ´Â »óŰ¡ µÇ¾ú½À´Ï´Ù. Á¶Á÷ º¸Á¸ ¹æ¹ýÀÇ ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.
¶ÇÇÑ, Å»¼¼Æ÷È¿Í °°Àº ¸ê±Õ ¹× °¡°ø ¹æ¹ýÀÇ Çõ½ÅÀº º´¿ø±ÕÀ» Á¦°ÅÇÏ°í ¸é¿ª¿ø¼ºÀ» ÃÖ¼ÒÈÇÏ¿© ÈûÁÙ µ¿Á¾À̽ÄÀÇ ¾ÈÀü¼º°ú È¿´ÉÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¼±À¸·Î ÀÌ½ÄÆí °ÅºÎ¹ÝÀÀÀÇ À§ÇèÀÌ °¨¼ÒÇÏ°í »ýü¿ªÇÐÀû Ư¼ºÀÌ ¾ÈÁ¤ÀûÀ¸·Î À¯ÁöµÇ¸é¼, ¿Ü°úÀÇ»ç¿Í ȯÀÚµé »çÀÌ¿¡¼ µ¿Á¾ ÀÌ½ÄÆí¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ÀÌ½Ä ¼ö¼ú ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, Á¦ÇÑµÈ °ø¿© Á¶Á÷ µîÀÇ ¹®Á¦·Î ÀÎÇØ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦¿¡µµ ºÒ±¸Çϰí, ÃÖ¼Òħ½À ¼ö¼ú¹ýÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÏ°í ½ºÆ÷Ã÷ °ü·Ã ºÎ»óÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀº ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÛÀº Àý°³Ã¢°ú Ư¼ö ±â±¸¸¦ »ç¿ëÇÏ´Â ÀÌ·¯ÇÑ ¼ö¼úÀº ȸº¹ ½Ã°£ ´ÜÃà°ú ¼ö¼ú ÈÄ ÅëÁõ °¨¼Ò µîÀÇ ÀÌÁ¡À» °¡Á®¿Í ÈûÁÙ µ¿Á¾À̽Ŀ¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ûÁ¤ ¿¡³ÊÁö ¹× ¿ìÁÖ °³¹ßÀÇ Â÷¼¼´ë Á¦Ç°¿¡ ÇÊ¿äÇÑ ½Å¼ÒÀç ¹× º¹ÇÕÀç¿¡ ´ëÇÑ Àû¿ë È®´ëµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è ÈûÁÙ µ¿Á¾ÀÌ½Ä ½ÃÀå Á¶»ç ´ë»ó ÁÖ¿ä Áö¿ªÀ¸·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«°¡ Æ÷ÇԵǸç, 2023³â ºÏ¹Ì°¡ ¼¼°è ÈûÁÙ µ¿Á¾ÀÌ½Ä ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â ACL ÆÄ¿, °ÇÆÇ ÆÄ¿, ¾ÆÅ³·¹½º °Ç ÆÄ¿°ú °°Àº ½ºÆ÷Ã÷ °ü·Ã ºÎ»óÀÇ ³ôÀº ¹ß»ý·ü¿¡ ±âÀÎÇÕ´Ï´Ù. ½ºÆ÷Ã÷ ¹× ½Åü Ȱµ¿ Âü¿©°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ºÆ÷Ã÷ ¼±¼ö¿Í Ȱµ¿ÀûÀÎ »ç¶÷µé »çÀÌ¿¡¼ Àç°Ç ¼ö¼ú¿ë ÈûÁÙ µ¿Á¾À̽Ŀ¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÏ¹Ì´Â ÀÇ·á Çõ½ÅÀÇ Áß½ÉÁö·Î¼ Á¶Á÷ °¡°ø ±â¼ú, ¼ö¼ú µµ±¸ ¹× ÀçȰ ÇÁ·ÎÅäÄÝÀÌ Áö¼ÓÀûÀ¸·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú ±â¼ú, Á¶Á÷ °øÇÐ, »ý¹°ÇÐÀû º¸°°ú °°Àº ÷´Ü ±â¼úÀº ¼ö¼ú °á°ú¿Í ȯÀÚ È¸º¹À» °³¼±ÇÏ¿© ÈûÁÙ µ¿Á¾ÀÌ½Ä ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾çÀº 2024-2032³â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
The Global Tendon Allograft Market is valued approximately at USD 67.39 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2024-2032. Tendon allografts, harvested from human cadavers, are increasingly preferred for orthopedic surgeries to repair torn or damaged tendons due to their efficiency in reducing surgery time and avoiding additional injuries to the patient's tissues. The advancements in tendon allograft processing and preservation techniques have significantly extended the shelf life of allografts, ensuring a ready supply for surgical procedures without compromising on quality. This technological progression in tissue preservation methods is pivotal in driving market growth.
Moreover, innovations in sterilization and processing methods, such as decellularization, have enhanced the safety and efficacy of tendon allografts by eliminating pathogens and minimizing immunogenicity. These improvements reduce the risk of graft rejection and ensure the retention of biomechanical properties, thereby increasing the preference for allografts among surgeons and patients. However, the market faces challenges such as the high cost of allograft procedures, stringent regulatory requirements, and limited availability of donor tissues, which can hinder market growth. Despite these challenges, the market is poised for growth due to the rising adoption of minimally invasive surgical techniques and the increasing incidence of sports-related injuries. These techniques, which involve smaller incisions and specialized instruments, offer benefits such as shorter recovery times and reduced postoperative pain, further boosting the demand for tendon allografts. Additionally, expanding applications in new materials and composites required for next-generation products in clean energy and space exploration are expected to bolster market growth.
The key regions considered for the Global Tendon Allograft Market study include Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. In year 2023, North America led the global tendon allograft market. This dominance is attributed to the high incidence of sports-related injuries, such as ACL tears, rotator cuff tears, and Achilles tendon ruptures. With the increasing participation in sports and physical activities, the demand for tendon allografts for reconstructive surgeries among athletes and active individuals is rising. Additionally, North America is a hub for medical innovation, with continuous advancements in tissue processing techniques, surgical instrumentation, and rehabilitation protocols. Cutting-edge technologies, including minimally invasive surgical techniques, tissue engineering, and biologic augmentation, are driving the growth of the tendon allograft market by enhancing surgical outcomes and patient recovery. Moreover, Asia Pacific is projected to registered fastest growth in the forecasted period 2024-2032.